Industrials

Companies Provide Additional Color on Infinite’s Business Model, Market Opportunity and Capital Plan, and Respond to Murchinson Ltd.’s Letter

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global GLP-1 Receptor Agonist Market size & share revenue was valued at approximately USD 28.7 Billion in 2025 and is expected to reach USD 34.2 Billion in 2026 and is expected to reach around USD 95.3 Billion by 2035, at a CAGR of 12.1% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Pfizer Inc., Merck & Co. Inc., Zealand Pharma A/S, Hanmi Pharmaceutical Co. Ltd. and others.

GRIMSBY, Ontario, June 16, 2026 (GLOBE NEWSWIRE) -- Andrew Peller Limited (TSX: ADW.A / ADW.B) (“APL” or the “Company”) announced today results for the three and 12 months ended March 31, 2026. All amounts are expressed in Canadian dollars unless otherwise stated.

MONTREAL, June 16, 2026 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or the “Company”) is aware of a report published by a short seller on June 16, 2026. The Company is confident that its current disclosure provides its investors with accurate and comprehensive information regarding Gildan, including with respect to its financial information and governance practices.

OVERLAND PARK, Kan., June 16, 2026 (GLOBE NEWSWIRE) -- Indra Group USA, a global leader in air traffic management and mobility technology, announces the successful commissioning of the Federal Aviation Administration's (FAA) first newly operational secondary radar, installed in Putnam, Oklahoma. This installation represents the first of 185 primary and secondary radars that are being deployed as part of the historic Radar System Replacement program to replace the nation’s aging, 1980s-era surveillance infrastructure.